Finding better therapeutic targets for patients with asthma: Adenosine receptors?

British Journal of Pharmacology

Volumn 155, Issue 4, 2008, Pages 441-443

  Polosa, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Adenosine; Adenosine receptor agonists; Adenosine receptor antagonists; Adenosine receptors; Airways; Asthma; Inflammation

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; BAMIFYLLINE; CORTICOSTEROID; ENPROFYLLINE; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CHRONIC INFLAMMATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; HUMAN; NONHUMAN; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECEPTOR AFFINITY;

ADENOSINE; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; PURINERGIC P1 RECEPTOR AGONISTS; PURINERGIC P1 RECEPTOR ANTAGONISTS;

EID: 53849147211     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.364     Document Type: Note

References (14)

1. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al. (2008). Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178.
2. Blackburn MR, Lee CG, Young HW, Zhu Z, Chunn JL, Kang MJ et al. (2003). Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 112: 332-344.
3. Brown RA, Clarke GW, Ledbetter CL, Hurle MJ, Denyer JC, Simcock DE et al. (2008). Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Eur Respir J 31: 311-319.
4. Caruso M, Tringali G, Polosa R (2007). Evidence for a functional contribution of adenosine signalling in inflammatory airway diseases. Immunol Endocr Metabol Agents Med Chem 4: 286-297.
5. Fortin A, Harbour D, Fernandes M, Borgeat P, Bourgoin S (2006). Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide. J Leukoc Biol 79: 574-585.
6. Holgate ST, Polosa R (2006). The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 368: 780-793.
7. Holgate ST, Polosa R (2008). Treatment strategies for allergy and asthma. Nat Rev Immunol 8: 218-230.
8. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B et al. (2003). Indirect airway challenges. Eur Respir J 21: 1050-1068.
9. Linden J (2005). Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 67: 1385-1387.
10. Polosa R, Morjaria J (2008). Immunomodulators and biologics for severe refractory asthma: an evidence-based review. Respir Med 22 (in press).
11. Press NJ, Gessi S, Borea P, Polosa R (2007). Therapeutic potential of adenosine receptor antagonists and agonists. Exp Opin Ther Pat 17: 979-991.
12. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB et al. (2004). Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 114: 40-47.
13. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L (2001). Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy 21: 1464-1467.
14. Wilson CN (2008). Adenosine receptors and asthma in humans. Br J Pharmacol 155: 475-486 (this issue).